Testing effectiveness (Phase 2)Study completedNCT02035553
What this trial is testing
The Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis
Who this might be right for
Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc. 181